Lifecore Biomedical Overview
Lifecore Biomedical (LNDC) has a ROE of 106.28%, above the Materials sector average of 19.82%.
Get informed when a big investor buys or sells
+ Follow106.28%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, LNDC shows a ROE of 106.28%. That is above the Materials sector average of 19.82%. Scroll down for historical charts and peer comparison views.
The Materials sector average ROE is about 19.82%. Lifecore Biomedical is at 106.28%, which is higher that average. That is roughly 436.1% above the sector mean. Use the comparison chart on this page to see how LNDC stacks up against individual peers as well.
Check the historical chart to see whether LNDC's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Lifecore Biomedical with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Lifecore Biomedical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 106.28%) with ownership activity and broader fundamentals.
The Materials average ROE is about 19.82%, while LNDC is at 106.28%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
